Novel Multi-functional Small Molecule TBN Proves Promising in ALS Phase II Trial

Time: 2:10 pm
day: Day Two Track B PM


  • Optimizing recruitment strategy to achieve a significantly large phase 2 cohort of Chinese patients
  • Outlining the observed effects on grip strength and other key markers of ALS progression
  • Advancing TBN into a phase 3 study in China